The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line

Carcinogenesis

Volumn 25, Issue 10, 2004, Pages 1839-1846

  Baumann Kubetzko, Florian B ^a   di Paolo, Claudio ^a   Maag, Charlotte ^a   Meier, Roland ^c   Schäfer, Beat W ^c   Betts, David R ^c   Stahel, Rolf A ^a   Himmelmann, Andreas ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Medizinische Klinik Zurich   (Switzerland)

^c Universitats Kinderklinik   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PAX5;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; MOUSE; NEUROBLASTOMA; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; CARCINOMA, SMALL CELL; CELL DIVISION; DNA-BINDING PROTEINS; FEMALE; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED ICR; MICE, NUDE; NEUROBLASTOMA; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 6444233371     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh190     Document Type: Article

References (39)

1. Brodeur,G.M. (2003) Neuroblastoma: biological insights into a clinical enigma. Nature Rev. Cancer, 3, 203-216.
2. Spix,C., Aareleid,T., Stiller,C., Magnani,C., Kaatsch,P. and Michaelis,J. (2001) Survival of children with neuroblastoma. Time trends and regional differences in Europe, 1978-1992. Eur. J. Cancer, 37, 722-729.
3. Le Douarin,N. and Kalcheim,C. (1999) The Neural Crest. Cambridge University Press, Cambridge.
4. Ciccarone,V., Spengler,B.A., Meyers,M.B., Biedler,J.L. and Ross,R.A. (1989) Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res., 49 219-225.
5. Thiele,C.J. (1999) Neuroblastoma. In Masters,J.R.W. and Palsson,B. (eds), Human Cell Culture. Kluwer Academic Publishers, Dordrecht, The Netherlands, Vol. 1, pp. 21-53.
6. Ross,R.A., Spengler,B.A., Domenech,C., Porubcin,M., Rettig,W.J. and Biedler,J.L. (1995) Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell Growth Differ., 6, 449-456.
7. Ross,R.A., Hein,A.M., Braca,J.A.,3rd, Spengler,B.A., Biedler,J.L. and Scammell,J.G. (2002) Glucocorticoids induce neuroendocrine cell differentiation and increase expression of N-myc in N-type human neuroblastoma cells. Oncol. Res., 13, 87-94.
8. Biedler,J.L., Spengler,B.A.,T.,C. and Ross,R.A. (1988) Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties. In Evans,A., D'Angio,G., Knudson,A. and Seeger,R. (eds), Advances in Neuroblastoma Research 2 Alan R. Liss, Inc., New York, pp. 265-276.
9. La Quaglia,M.P. and Manchester,K.M. (1996) A comparative analysis of neuroblastic and substrate-adherent human neuroblastoma cell lines. J. Pediatr. Surg., 31, 315-318.
10. Isaacs,J.S., Hardman,R., Carman,T.A., Barrett,J.C. and Weissman,B.E. (1998) Differential subcellular p53 localization and function in N- and S-type neuroblastoma cell lines. Cell Growth Differ., 9, 545-555.
11. Sadee,W., Yu,V.C., Richards,M.L., Preis,P.N., Schwab,M.R., Brodsky,F.M. and Biedler,J.L. (1987) Expression of neurotransmitter receptors and myc protooncogenes in subclones of a human neuroblastoma cell line. Cancer Res., 47, 5207-5212.
12. Foley,J., Cohn,S.L., Salwen,H.R., Chagnovich,D., Cowan,J., Mason,K.L. and Parysek,L.M. (1991) Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line. Cancer Res., 51, 6338-6345.
13. Hopkins-Donaldson,S., Bodmer,J.L., Bourloud,K.B., Brognara,C.B., Tschopp,J. and Gross,N. (2000) Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res., 60, 4315-4319.
14. Eggert,A., Grotzer,M.A., Zuzak,T.J., Wiewrodt,B.R., Ikegaki,N. and Brodeur,G.M. (2000) Resistance to TRAIL-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Med. Pediatr. Oncol., 35, 603-607.
15. Chi,N. and Epstein,J.A. (2002) Getting your Pax straight: Pax proteins in development and disease. Trends Genet., 18, 41-47.
16. Asano,M. and Gruss,P. (1992) Pax-5 is expressed at the midbrain-hindbrain boundary during mouse development. Mech. Dev., 39, 29-39.
17. Gerard,M., Abitbol,M., Delezoide,A.L., Dufier,J.L., Mallet,J. and Vekemans,M. (1995) PAX-genes expression during human embryonic development, a preliminary report. C. R. Acad. Sci. III, 318, 57-66.
18. Adams,B., Dorfler,P., Aguzzi,A., Kozmik,Z., Urbanek,P., Maurer-Fogy,I. and Busslinger,M. (1992) Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS and adult testis. Genes Dev., 6, 1589-1607.
19. Urbanek,P., Fetka,I., Meisler,M.H. and Busslinger,M. (1997) Cooperation of Pax2 and Pax5 in midbrain and cerebellum development. Proc. Natl Acad. Sci USA, 94, 5703-5708.
20. Schafer,B.W. (1998) Emerging roles for PAX transcription factors in cancer biology. Gen. Physiol. Biophys., 17, 211-224.
21. Kozmik,Z, Sure,U., Ruedi,D., Busslinger,M. and Aguzzi,A. (1995) Deregulated expression of PAX5 in medulloblastoma. Proc. Natl Acad. Sci. USA, 92, 5709-5713.
22. Krenacs,L., Himmelmann,A.W., Quintanilla-Martinez,L., Fest,T., Riva,A., Wellmann,A., Bagdi,E., Kehrl,J.H., Jaffe,E.S. and Raffeld,M. (1998) Transcription factor B-cell-specific activator protein (BSAP) is differentially expressed in B cells and in subsets of B-cell lymphomas. Blood, 92, 1308-1316.
23. Scholl,F.A., Kamarashev,J., Murmann,O.V., Geertsen,R., Dummer,R. and Schafer,BW. (2001) PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res., 61, 823-826.
24. Hopkins-Donaldson,S., Ziegler,A., Kurtz,S., Bigosch,C., Kandioler,D., Ludwig,C., Zangemeister-Wittke,U. and Stahel,R. (2003) Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ. 10, 356-364.
25. Adshead,J.M., Ogden,C.W., Penny,M.A., Stuart,E.T. and Kessling,A.M. (1999) The expression of PAX5 in human transitional cell carcinoma of the bladder: relationship with de-differentiation. Br. J. Urol. Int., 83, 1039-1044.
26. Sambrook,J. and Russell,D.W. (2001) Molecular Cloning A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
27. Koesters,R., Niggli,F., von Knebel Doeberitz,M. and Stallmach,T. (2003) Nuclear accumulation of beta-catenin protein in Wilms' tumours. J. Pathol., 199, 68-76.
28. Olie,R.A., Hall,J., Natt,F., Stahel,R.A. and Zangemeister-Wittke,U. (2002) Analysis of ribosyl-modified, mixed backbone analogs of a bcl-2/bcl-xL antisense oligonucleotide. Biochim. Biophys. Acta, 1576, 101-109.
29. Busslinger,M., Klix,N., Pfeffer,P., Graninger,P.G. and Kozmik,Z. (1996) Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma. Proc. Natl Acad. Sci. USA, 93, 6129-6134.
30. Morrison,A.M., Jager,U., Chott,A., Schebesta,M., Haas,O.A. and Busslinger,M. (1998) Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma. Blood, 92 3865-3878.
31. Fire,A., Xu,S., Montgomery,M.K., Kostas,S.A., Driver,S.E. and Mello,C.C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature, 391, 806-811.
32. Cohen,N., Betts,D.R., Rechavi,G., Amariglio,N. and Trakhtenbrot,L. (2003) Clonal expansion and not cell interconversion is the basis for the neuroblast and nonneuronal types of the SK-N-SH neuroblastoma cell line. Cancer Genet. Cytogenet., 143, 80-84.
33. Suardet,L., Gross,N., Gaide,A.C., Beck,D. and Eliason,J.F. (1989) Epidermal growth factor responsiveness of a new human neuroblastoma cell line. Int. J. Cancer, 44, 661-668.
34. Scheidler,S., Fredericks,W.J., Rauscher,F.J.,3rd, Barr,F.G. and Vogt,P.K. (1996) The hybrid PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma transforms fibroblasts in culture. Proc. Natl Acad. Sci. USA, 93, 9805-9809.
35. Anderson,M.J., Sheiton,G.D., Cavenee,W.K. and Arden,K.C. (2001) Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3. Proc. Natl Acad. Sci. USA, 98, 1589-1594.
36. Lagutina,I., Conway,S.J., Sublett,J. and Grosveld,G.C. (2002) Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors. Mol. Cell. Biol., 223, 7204-7216.
37. Steinbach,J.P., Kozmik,Z., Pfeffer,P. and Aguzzi,A. (2001) Overexpression of Pax5 is not sufficient for neoplastic transformation of mouse neuroectoderm. Int. J. Cancer, 93, 459-467.
38. Wakatsuki,Y., Neurath,M.F., Max,E.E. and Strober,W. (1994) The B cell-specific transcription factor BSAP regulates B cell proliferation. J. Exp. Med., 179, 1099-1108.
39. Muratovska,A., Zhou,C., He,S., Goodyer,P. and Eccles,MR. (2003) Paired-box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene, 22, 6045-6053.